Conflict of interest
D.G. received honoraria for speaking at meetings from Sanofi, Eli Lilly, and Company, AstraZeneca, and Novo Nordisk. M.I.M. received honoraria for speaking at meetings from Novo Nordisk, Sanof, and Eli-Lilly. K.E. received honoraria for speaking at meetings from Sanofi Aventis, Eli Lilly, and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.